This hormone was then patented, synthesized, mass-produced, and sold under the brand name Byetta (or Bydureon)
Williams, president of the Boston consulting firm Health Business Group, welcomed the move by the Trump administration to lower the cost of GLP-1s
The experimental drug drove solid weight loss when taken once a month in a mid-stage trial offering early evidence that the injection can be administered less frequently than existing drugs without sacrificing efficacy
By integrating biological, psychological, and experiential dimensions, future strategies can move toward more personalized, durable, and patient-centered obesity care
Emmerich SD, Fryar CD, Stierman B, Ogden CL
[PubMed ID: 18346892]